Agenda
The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. The committee will meet in open session to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified..
Meeting Materials
FDA intends to make background material available to the public no later than 2 business days before the meeting.
Concept Cloud
